Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine

被引：0
|
作者：
Yoshinori Ito
Yohei Osaki
Nahomi Tokudome
Tsutomu Sugihara
Shunji Takahashi
Takuji Iwase
Kiyohiko Hatake
机构：
[1] The Cancer Institute of Japanese Foundation for Cancer Research,Department of Medical Oncology
[2] Cancer Institute Hospital,Department of Breast Oncology
[3] Japanese Foundation for Cancer Research,undefined
来源：
Breast Cancer | 2009年 / 16卷
关键词：
S-1; Capecitabine; Taxane; Anthracycline; Metastatic breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：126 / 131
页数：5
相关论文
共 50 条
  • [21] ADHERENCE TO AND PERSISTENCE WITH AN ORAL METRONOMIC CHEMOTHERAPY WITH CAPECITABINE IN HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS
    Mazzoni, E.
    Fedele, P.
    Orlando, L.
    Marino, A.
    D'Amico, M.
    Sponziello, F.
    Nacci, A.
    Calvani, N.
    Schiavone, P.
    Rizzo, P.
    Chetri, M. C.
    Cinieri, S.
    CANCER TREATMENT REVIEWS, 2010, 36 : S101 - S101
  • [22] Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
    Pin Zhang
    Zhongsheng Tong
    Fuguo Tian
    Yongsheng Wang
    Junlan Yang
    Weilian Li
    Lijun Di
    Wei Liu
    Li Tang
    Rongguo Qiu
    Binghe Xu
    Journal of Hematology & Oncology, 9
  • [23] Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer.
    Ates, Ozturk
    Babacan, Taner
    Sarici, Furkan
    Kertmen, Neyran
    Cenoli, Alma
    Akin, Serkan
    Karakas, Yusuf
    Kilickap, Saadettin
    Aksoy, Sercan
    Ozisik, Yavuz Yasin
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Biweekly gemcitabine and capecitabine in heavily pretreated patients with metastatic colorectal cancer (mCRC)
    Solis Hernandez, Maria Del Pilar
    Jimenez, Paula
    Faez Garcia, Laura
    Alvarez Fernandez, Carlos
    Perez Arnillas, Quionia
    Rodriguez Rubi, David Jose
    Lucrecia Ruiz, Ana
    Sanchez Lorenzo, Luisa
    Li Torres, Walter Antonio
    Uriol, Esther
    Dolores, Maria
    Prieto, Menendez
    Maria Vieitez de Prado, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Patient preference trial comparing capecitabine and S-1 in metastatic breast cancer patients.
    Yamamoto, Daigo
    Iwase, Satoru
    Yamaguchi, Takuhiro
    Tsubota, Yu
    Kawaguchi, Takashi
    Odagiri, Hiroki
    Ariyoshi, Keisuke
    Kitamura, Kaoru
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Thalidomide is inactive in heavily pretreated patients with metastatic breast cancer
    Morabito, A
    Carillio, G
    Longo, R
    Gasparini, G
    CANCER JOURNAL, 2005, 11 (03): : 248 - 251
  • [27] Fulvestrant in metastatic breast cancer: Safety, efficacy, and role as mainteinance therapy for heavily pretreated patients
    Carillio, G.
    Scandurra, G.
    Aiello, R.
    Taibi, E.
    Mazzola, A.
    Ali, M.
    Bagnato, S.
    Fallica, G.
    Chiarenza, M.
    Caruso, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer
    Sym, Sun Jin
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Lee, Won-Suk
    Baek, Jeong-Heum
    Park, Yeon Ho
    Shin, Dong Bok
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [29] A PHASE II TRIAL OF SALVAGE TREATMENT WITH GEMCITABINE AND S-1 COMBINATION IN HEAVILY PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER
    Sym, S. J.
    Hong, J.
    Jung, M.
    Park, J.
    Cho, E. K.
    Lee, J. H.
    Lee, W. -S.
    Baek, J. -H.
    Shin, D. B.
    ANNALS OF ONCOLOGY, 2012, 23 : 151 - 152
  • [30] A PHASE 2 TRIAL OF SALVAGE TREATMENT WITH GEMCITABINE AND S-1 COMBINATION IN HEAVILY PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER
    Sym, S. J.
    Hong, J.
    Ahn, H. K.
    Park, J.
    Cho, E. K.
    Lee, J. H.
    Lee, W.
    Baek, J.
    Park, Y. H.
    Shin, D. B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S3 - S3
12345